Enhancement of antitumor immunity in lung cancer by targeting myeloid-derived suppressor cell pathways

Chemoresistance due to heterogeneity of the tumor microenvironment (TME) hampers the long-term efficacy of frontline therapies for lung cancer. Current combination therapies for lung cancer provide only modest improvement in survival, implicating necessity for novel approaches that suppress malignan...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Sawant, Anandi, Schafer, Cara C., Jin, Tong Huan, Zmijewski, Jaroslaw, Tse, Hubert M., Roth, Justin, Sun, Zhihuan, Siegal, Gene P., Thannickal, Victor J., Grant, Stefan C., Ponnazhagan, Selvarangan, Deshane, Jessy S.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3854493/
https://ncbi.nlm.nih.gov/pubmed/24085788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0987
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg